Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06485206 · ClinicalTrials.gov registry record · NA
Evaluation of Safety and Effectiveness of Primary Hybrid Construct of Mobi-C and ACDF in the Treatment of Two-level Symptomatic Degenerative Disc Disease in the Cervical Spine.
A NA study of Degenerative Disc Disease, sponsored by Highridge Medical.
- Recruiting
- Registry status
- NA
- Development phase
- 97
- Enrollment target
- 2
- Study locations
NCT06485206 is a NA study of Degenerative Disc Disease that is actively recruiting participants, run by Highridge Medical. The registered enrollment target is 97 participants, below the 166-participant average among 42 other Degenerative Disc Disease trials with a reported enrollment target (42% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT06485206, a NA study of Degenerative Disc Disease, is actively recruiting participants, sponsored by Highridge Medical.
- RECRUITING
- Registry status
- NA
- Development phase
- 97 participants
- Enrollment target
- 2
- Study locations
Study Summary
The study is a prospective, multi-center cohort study of patients with two-level DDD implanted with CDA adjacent to ACDF (hybrid construct). The overall success of the hybrid procedure will be compared to 2-level ACDF historical controls from the Mobi-C IDE trial. 97 patients will receive the hybrid surgery and will be followed for a minimum of 2 years.
Conditions Studied
Interventions
- DEVICE One level Mobi-C and one level fusion
Study Locations (2)
California
- University of California-Davis - Sacramento
Michigan
- Michigan Orthopaedic Surgeons - Southfield
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 97 participants |
| Start Date | 2024-09-01 |
| Est. Completion | 2029-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06485206
The ClinicalTrials.gov registry entry for NCT06485206 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 97 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 166-participant average among 42 other Degenerative Disc Disease trials with a reported enrollment target (42% lower). The listed sponsor is Highridge Medical, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Degenerative Disc Disease appearing as the primary indexed condition, and to 1 intervention - of which One level Mobi-C and one level fusion is the first listed.
NCT06485206 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Michigan.
Frequently Asked Questions
What is clinical trial NCT06485206 about?
NCT06485206 is a clinical study titled "Evaluation of Safety and Effectiveness of Primary Hybrid Construct of Mobi-C and ACDF in the Treatment of Two-level Symptomatic Degenerative Disc Disease in the Cervical Spine.". The study is a prospective, multi-center cohort study of patients with two-level DDD implanted with CDA adjacent to ACDF (hybrid construct). The overall success of the hybrid procedure will be compared to 2-level ACDF historical controls from the Mobi-C IDE trial. 97 patients will receive the hybrid...
What is the current status of trial NCT06485206?
This trial is currently recruiting. It is a NA study. The enrollment target is 97 participants. The study started on 2024-09-01. Estimated completion is 2029-05.
What conditions does trial NCT06485206 study?
This clinical trial studies the following conditions: Degenerative Disc Disease.
What interventions are being tested in trial NCT06485206?
The interventions under investigation include: One level Mobi-C and one level fusion (DEVICE).
Who is sponsoring clinical trial NCT06485206?
This trial is sponsored by Highridge Medical, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06485206 being conducted?
This trial has 2 study locations across California, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Degenerative Disc Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Investigation of DEXA-C Anterior Cervical Interbody System
RECRUITING · NA
-
Post Marketing Study of MagnetOs Easypack Putty Standalone Compared to Demineralized Bone Matrix or Fibers Mixed With Autograft in Patients Undergoing Posterolateral Lumbar Fusion
RECRUITING · NA
-
Trial for Treating Painful Degenerative Disc Disease
RECRUITING · NA
-
MagnetOs Flex Matrix Compared to Trinity Elite Mixed With Local Autograft in Patients Undergoing up to Four-level Instrumented Posterolateral Fusion
RECRUITING · NA
-
ACDF Using Structural Allograft vs. Tritanium C
RECRUITING · NA
-
Clinical Trial Evaluating the Safety and Efficacy of Nucleus Pulposus Allograft in Participants With Degenerative Disc Disease
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.